Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Alcazer

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Haematologica|February 24, 2022
Diagnosis of acute promyelocytic leukemia based on routine biological parameters using machine learningEstelle Cheli, Simon Chevalier, Olivier Kosmider, et al.
Frontiers in Immunology|August 15, 2022
A Simple-to-Perform <i>ifn-γ</i> mRNA Gene Expression Assay on Whole Blood Accurately Appraises Varicella Zoster Virus-Specific Cell-Mediated Immunity After Allogeneic Hematopoietic Stem Cell TransplantationMathilde Boccard, Anne Conrad, William Mouton, et al.
Frontiers in Immunology|March 21, 2022
Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaAnne-Marie Daull, Valérie Dubois, Hélène Labussière-Wallet, et al.
Leukemia Research|August 9, 2016
CML patients show sperm alterations at diagnosis that are not improved with imatinib treatmentFranck-Emmanuel Nicolini, Vincent Alcazer, Françoise Huguet, et al.
Transplantation and Cellular Therapy|March 9, 2025
Temporal Evolution of Functional Immune Reconstitution after Allogeneic HSCTWilliam Mouton, Léa Aguilhon, Vincent Alcazer, et al.
Transplantation and Cellular Therapy|November 6, 2022
Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell TransplantationWilliam Mouton, Anne Conrad, Vincent Alcazer, et al.
Hemasphere|November 17, 2025
HLA diversity is associated with TKI response and treatment-free remission in chronic myeloid leukemiaCharles Toulemonde, Valérie Dubois, Christophe Bouvier, et al.
Cell Death Discovery|July 16, 2024
Human myeloid differentiation by BMP4 signaling through the VDR pathway in acute myeloid leukemiaFlorence Zylbersztejn, Iryna Byelinska, Sandrine Jeanpierre, et al.
Leukemia|May 20, 2025
Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma modelGamze Tari Crochet, Selcen Ari-Yuka, Anja Fischer, et al.
Communications Biology|November 23, 2024
Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathwaysDonia Hidaoui, Audrey Porquet, Rabie Chelbi, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Haematologica|February 24, 2022
Diagnosis of acute promyelocytic leukemia based on routine biological parameters using machine learningEstelle Cheli, Simon Chevalier, Olivier Kosmider, et al.
Frontiers in Immunology|August 15, 2022
A Simple-to-Perform <i>ifn-γ</i> mRNA Gene Expression Assay on Whole Blood Accurately Appraises Varicella Zoster Virus-Specific Cell-Mediated Immunity After Allogeneic Hematopoietic Stem Cell TransplantationMathilde Boccard, Anne Conrad, William Mouton, et al.
Frontiers in Immunology|March 21, 2022
Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaAnne-Marie Daull, Valérie Dubois, Hélène Labussière-Wallet, et al.
Leukemia Research|August 9, 2016
CML patients show sperm alterations at diagnosis that are not improved with imatinib treatmentFranck-Emmanuel Nicolini, Vincent Alcazer, Françoise Huguet, et al.
Transplantation and Cellular Therapy|March 9, 2025
Temporal Evolution of Functional Immune Reconstitution after Allogeneic HSCTWilliam Mouton, Léa Aguilhon, Vincent Alcazer, et al.
Transplantation and Cellular Therapy|November 6, 2022
Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell TransplantationWilliam Mouton, Anne Conrad, Vincent Alcazer, et al.
Hemasphere|November 17, 2025
HLA diversity is associated with TKI response and treatment-free remission in chronic myeloid leukemiaCharles Toulemonde, Valérie Dubois, Christophe Bouvier, et al.
Cell Death Discovery|July 16, 2024
Human myeloid differentiation by BMP4 signaling through the VDR pathway in acute myeloid leukemiaFlorence Zylbersztejn, Iryna Byelinska, Sandrine Jeanpierre, et al.
Leukemia|May 20, 2025
Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma modelGamze Tari Crochet, Selcen Ari-Yuka, Anja Fischer, et al.
Communications Biology|November 23, 2024
Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathwaysDonia Hidaoui, Audrey Porquet, Rabie Chelbi, et al.
Pageof 5